<--- Back to Details
First PageDocument Content
Combination drugs / Asthma / Budesonide/formoterol / Salmeterol / Formoterol / Fluticasone/salmeterol / Cromoglicic acid / Pharmaceutical drug / Mometasone/formoterol / Pulmonology / Medicine / Respiratory therapy
Date: 2012-04-03 02:18:55
Combination drugs
Asthma
Budesonide/formoterol
Salmeterol
Formoterol
Fluticasone/salmeterol
Cromoglicic acid
Pharmaceutical drug
Mometasone/formoterol
Pulmonology
Medicine
Respiratory therapy

The University of Sydney at Westmead Hospital Australian General Practice Statistics and Classification Centre Family Medicine Research Centre

Add to Reading List

Source URL: sydney.edu.au

Download Document from Source Website

File Size: 234,76 KB

Share Document on Facebook

Similar Documents

As at AugustAstraZeneca’s Environmental Risk Summaries As part of AstraZeneca’s ongoing commitment to environmental data transparency, this website provides environmental risk summaries for the Active Pharmace

As at AugustAstraZeneca’s Environmental Risk Summaries As part of AstraZeneca’s ongoing commitment to environmental data transparency, this website provides environmental risk summaries for the Active Pharmace

DocID: 1rlq4 - View Document

Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth

Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth

DocID: 1oNoo - View Document

European Respiratory Disease Volume 8 • Issue 1 • Spring 2012 • Extract Improved Localised Lung Delivery Using

European Respiratory Disease Volume 8 • Issue 1 • Spring 2012 • Extract Improved Localised Lung Delivery Using

DocID: 1ooQZ - View Document

ORIGINAL CONTRIBUTION  How Conducting a Clinical Trial Affects Physicians’ Guideline Adherence and Drug Preferences Morten Andersen, MD, PhD

ORIGINAL CONTRIBUTION How Conducting a Clinical Trial Affects Physicians’ Guideline Adherence and Drug Preferences Morten Andersen, MD, PhD

DocID: 1aqMg - View Document

19th International Congress on Modelling and Simulation, Perth, Australia 12–16 December 2011 http://mssanz.org.au/modsim2011 Trends in Chronic Obstructive Pulmonary Disease Hospitalization Rates in TexasS.

19th International Congress on Modelling and Simulation, Perth, Australia 12–16 December 2011 http://mssanz.org.au/modsim2011 Trends in Chronic Obstructive Pulmonary Disease Hospitalization Rates in TexasS.

DocID: 182ik - View Document